{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:40:58Z","timestamp":1791726058605,"version":"4.3.4"},"reference-count":88,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T00:00:00Z","timestamp":1595548800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Fundamemntal Clinical Pharma"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Patients with COVID\u201019 are sometimes already being treated for one or more other chronic conditions, especially if they are elderly. Introducing a treatment against COVID\u201019, either on an outpatient basis or during hospitalization for more severe cases, raises the question of potential drug\u2013drug interactions. Here, we analyzed the potential or proven risk of the co\u2010administration of drugs used for the most common chronic diseases and those currently offered as treatment or undergoing therapeutic trials for COVID\u201019. Practical recommendations are offered, where possible.<\/jats:p>","DOI":"10.1111\/fcp.12586","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T21:21:13Z","timestamp":1593552073000},"page":"530-547","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Potential drug\u2013drug interactions associated with drugs currently proposed for COVID\u201019 treatment in patients receiving other treatments"],"prefix":"10.1111","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0908-3629","authenticated-orcid":false,"given":"Florian","family":"Lemaitre","sequence":"first","affiliation":[{"name":"Univ Rennes CHU Rennes Inserm EHESP Irset (Institut de recherche en sant\u00e9, environnement et travail) \u2010 UMR_S 1085 Rennes F\u201035000 France"},{"name":"INSERM Centre d'Investigation Clinique CIC 1414 Rennes F\u201035000 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Solas","sequence":"additional","affiliation":[{"name":"Aix\u2010Marseille University APHM UMR \u201cEmergence des Pathologies Virales\u201d Inserm 1207 IRD 190 Laboratoire de Pharmacocin\u00e9tique et Toxicologie H\u00f4pital La Timone Marseille 13005 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1232-5761","authenticated-orcid":false,"given":"Matthieu","family":"Gr\u00e9goire","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Department CHU Nantes Nantes Cedex 1 Nantes 44093 France"},{"name":"UMR INSERM 1235 The Enteric Nervous System in Gut and Brain Disorders University of Nantes Nantes Cedex 1 Nantes 44093 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Lagarce","sequence":"additional","affiliation":[{"name":"Service de Pharmacologie\u2010Toxicologie et Pharmacovigilance Centre Hospitalo\u2010Universitaire d'Angers Angers 49100 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Elens","sequence":"additional","affiliation":[{"name":"Integrated Pharmacometrics, Pharmacogenomics and Pharmacokinetics (PMGK) Louvain Drug Research Institute (LDRI) Universit\u00e9 Catholique de Louvain (UCL) Louvain Belgique"},{"name":"Louvain Center for Toxicology and Applied Pharmacology (LTAP) Institut de Recherche Exp\u00e9rimentale et Clinique (IREC) Universit\u00e9 Catholique de Louvain (UCL) Louvain Belgique"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Polard","sequence":"additional","affiliation":[{"name":"Univ Rennes CHU Rennes Inserm EHESP Irset (Institut de recherche en sant\u00e9, environnement et travail) \u2010 UMR_S 1085 Rennes F\u201035000 France"},{"name":"INSERM Centre d'Investigation Clinique CIC 1414 Rennes F\u201035000 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Saint\u2010Salvi","sequence":"additional","affiliation":[{"name":"Medical Interactions Unit Agence National de S\u00e9curit\u00e9 du M\u00e9dicaments et des produits de sant\u00e9 Saint\u2010Denis 93200 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Sommet","sequence":"additional","affiliation":[{"name":"Department of Medical and Clinical Pharmacology Centre of PharmacoVigilance and Pharmacoepidemiology INSERM UMR 1027 CIC 1426 Toulouse University Hospital Faculty of Medicine University of Toulouse Toulouse 31000 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Tod","sequence":"additional","affiliation":[{"name":"Pharmacy Croix\u2010Rousse Hospital Lyon 69005 France"},{"name":"ISPB University Lyon 1 Lyon 69005 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Barin\u2010Le Guellec","sequence":"additional","affiliation":[{"name":"Laboratoire de Biochimie et de Biologie Mol\u00e9culaire CHU de Tours Tours F37044 France"},{"name":"Universit\u00e9 de Tours Tours F\u201037044 France"},{"name":"INSERM IPPRITT, U1248 Limoges F\u201087000 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the French Society of Pharmacology, Therapeutics (SFPT), the International Association of Therapeutic Drug Monitoring, Clinical Toxicology (IATDMCT)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,7,24]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001017"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/oby.22831"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa414"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-020-02105-8"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.047164"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14455"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.6019"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2008.302"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270010385118"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1435"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-018-0711-0"},{"key":"e_1_2_6_14_1","unstructured":"Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacologie et Th\u00e9rapeutique.Hot topics COVID\u201019 dans therapies. [Cited 2020 Apr 30]. Available from:https:\/\/sfpt\u2010fr.org\/groupes\u2010de\u2010travail\/m%C3%A9dicaments\u2010covid\u201019\/1166\u2010hot\u2010topics\u2010covid19."},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2016638"},{"key":"e_1_2_6_16_1","unstructured":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament.Plaquenil R\u00e9sum\u00e9 des caract\u00e9ristiques du produit [Internet]. [Cited 2020 Apr 23]. Available from:http:\/\/agence\u2010prd.ansm.sante.fr\/php\/ecodex\/frames.php?specid=67767535&typedoc=R&ref=R0351462.htm."},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1988.tb05281.x"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1844"},{"key":"e_1_2_6_19_1","unstructured":"University of Liverpool.COVID\u201019 drug interactions[Internet]. [Cited 2020 Apr 23]. Available from:https:\/\/www.covid19\u2010druginteractions.org\/."},{"key":"e_1_2_6_20_1","unstructured":"Drug Bank.Remdesivir[Internet]. [Cited 2020 Apr 23]. Available from:https:\/\/www.drugbank.ca\/drugs\/DB14761."},{"key":"e_1_2_6_21_1","unstructured":"EMA.Kaletra product information[Internet]. [Cited 2020 Apr 23]. Available from:https:\/\/www.ema.europa.eu\/en\/documents\/product\u2010information\/kaletra\u2010epar\u2010product\u2010information_en.pdf."},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31042-4"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2011.35"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-016-0462-8"},{"key":"e_1_2_6_25_1","unstructured":"EMA.Kineret product information[Internet]. [Cited 2020 Jun 17]. Available from:https:\/\/www.ema.europa.eu\/en\/documents\/product\u2010information\/kineret\u2010epar\u2010product\u2010information_en.pdf."},{"key":"e_1_2_6_26_1","unstructured":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament.Zithromax R\u00e9sum\u00e9 des caract\u00e9ristiques du produit[Internet]. [Cited 2020 Apr 23]. Available from:http:\/\/agence\u2010prd.ansm.sante.fr\/php\/ecodex\/frames.php?specid=65740799&typedoc=R&ref=R0338983.htm."},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep28698"},{"key":"e_1_2_6_28_1","article-title":"Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide\u2010spread use for COVID\u2010 19: a multinational, network cohort and self\u2010 controlled case series study","author":"Lane J.","year":"2020","journal-title":"medRxiv."},{"key":"e_1_2_6_29_1","unstructured":"EMA.Olumiant product information[Internet]. [Cited 2020 Jun 17]. Available from:https:\/\/www.ema.europa.eu\/en\/documents\/product\u2010information\/olumiant\u2010epar\u2010product\u2010information_en.pdf."},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30262-0"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30304-4"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000057"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1986"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000327"},{"key":"e_1_2_6_35_1","unstructured":"SFAR.Traitement anticoagulant pour la pr\u00e9vention du risque thrombotique chez un patient hospitalis\u00e9 avec Covid\u201019 et surveillance de l'h\u00e9mostase[Internet]. [Cited 2020 Apr 23]. Available from:https:\/\/sfar.org\/traitement\u2010anticoagulant\u2010pour\u2010la\u2010prevention\u2010du\u2010risque\u2010thrombotique\u2010chez\u2010un\u2010patient\u2010hospitalise\u2010avec\u2010covid\u201019\u2010et\u2010surveillance\u2010de\u2010lhemostase\/."},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-018-0637-6"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2012.163"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2010.03849.x"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2715"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.02.008"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241140-00004"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.12359"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmcr.2016.03.005"},{"key":"e_1_2_6_44_1","unstructured":"EMA.Edurant product information[Internet]. [Cited 2020 Apr 23]. Available from:https:\/\/www.ema.europa.eu\/en\/documents\/product\u2010information\/edurant\u2010epar\u2010product\u2010information_en.pdf."},{"key":"e_1_2_6_45_1","unstructured":"EMA.Celsentri product information[Internet]. [Cited 2020 Apr 23]. Available from:https:\/\/www.ema.europa.eu\/en\/documents\/product\u2010information\/celsentri\u2010epar\u2010product\u2010information_en.pdf."},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270010371113"},{"key":"e_1_2_6_47_1","volume-title":"9th International Workshop on Clinical Pharmacology of HIV therapy","author":"Rhame F.","year":"2008"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.02020.x"},{"key":"e_1_2_6_49_1","unstructured":"EMA.Recommendations on compassionate use of Remdesivir for COVID\u201019[Internet]. [Cited 2020 Apr 23]. Available from:https:\/\/www.ema.europa.eu\/en\/news\/ema\u2010provides\u2010recommendations\u2010compassionate\u2010use\u2010remdesivir\u2010covid\u201019."},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1505967"},{"key":"e_1_2_6_51_1","unstructured":"EMA.Vosevi product information[Internet]. [Cited 2020 Apr 23]. Available from:https:\/\/www.ema.europa.eu\/en\/documents\/product\u2010information\/vosevi\u2010epar\u2010product\u2010information_en.pdf."},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz439"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.117.078691"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal3653"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv447"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv606"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bulcan.2020.01.001"},{"key":"e_1_2_6_58_1","first-page":"318","article-title":"Drug interactions between antiretroviral and chemo\u2010\/ targeted therapy","volume":"6","author":"Courtillat E.","year":"2019","journal-title":"Innov. Therap. Oncologie"},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/anec.12225"},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.7"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2003.50171"},{"key":"e_1_2_6_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2007.02007.x"},{"key":"e_1_2_6_63_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000165111.09687.4E"},{"key":"e_1_2_6_64_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31823e7884"},{"key":"e_1_2_6_65_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000761"},{"key":"e_1_2_6_66_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.116.071456"},{"key":"e_1_2_6_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14335"},{"key":"e_1_2_6_68_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f288"},{"key":"e_1_2_6_69_1","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.309"},{"key":"e_1_2_6_70_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2003.02078.x"},{"key":"e_1_2_6_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2009.01482.x"},{"key":"e_1_2_6_72_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ftd.0000164609.14808.93"},{"key":"e_1_2_6_73_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1P759"},{"key":"e_1_2_6_74_1","doi-asserted-by":"publisher","DOI":"10.1300\/J069v24n01_05"},{"key":"e_1_2_6_75_1","doi-asserted-by":"publisher","DOI":"10.1136\/emj.2002.003251"},{"key":"e_1_2_6_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0736-4679(01)00379-1"},{"key":"e_1_2_6_77_1","first-page":"536","article-title":"Influence of rifampicin on hydroxychloroquine","volume":"13","author":"Harvey C.J.","year":"1995","journal-title":"Clin. Exp. Rheumatol."},{"key":"e_1_2_6_78_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.314.7094.1593"},{"key":"e_1_2_6_79_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2008.00579.x"},{"key":"e_1_2_6_80_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241010-00003"},{"key":"e_1_2_6_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.520"},{"key":"e_1_2_6_82_1","unstructured":"SFAR.Recommandations d'experts portant sur la prise en charge en r\u00e9animation des patients en p\u00e9riode d'\u00e9pid\u00e9mie \u00e0 SARS\u2010CoV2[Internet]. [Cited 2020 Apr 23]. Available from:https:\/\/sfar.org\/recommandations\u2010dexperts\u2010portant\u2010sur\u2010la\u2010prise\u2010en\u2010charge\u2010en\u2010reanimation\u2010des\u2010patients\u2010en\u2010periode\u2010depidemie\u2010a\u2010sars\u2010cov2\/."},{"key":"e_1_2_6_83_1","unstructured":"SFAR.La s\u00e9dation du patient Covid en r\u00e9animation: quelles sp\u00e9cificit\u00e9s?[Internet]. [Cited 2020 Apr 23]. Available from:https:\/\/sfar.org\/download\/la\u2010sedation\u2010du\u2010patient\u2010covid\u2010en\u2010reanimation\u2010quelles\u2010specificites\/."},{"key":"e_1_2_6_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30628-0"},{"key":"e_1_2_6_85_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCC.0000000000000503"},{"key":"e_1_2_6_86_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12331"},{"key":"e_1_2_6_87_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181961bff"},{"key":"e_1_2_6_88_1","unstructured":"BleyzacN. BourguignonL. GoutelleS. TodM.DDI predictor website Academic version[Internet]. [Cited 2020 Apr 23]. Available from:https:\/\/www.ddi\u2010predictor.org\/."},{"key":"e_1_2_6_89_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCC.0000000000000267"}],"container-title":["Fundamental &amp; Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ffcp.12586","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/fcp.12586","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/fcp.12586","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/fcp.12586","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T19:13:45Z","timestamp":1693941225000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/fcp.12586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,24]]},"references-count":88,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["10.1111\/fcp.12586"],"URL":"https:\/\/doi.org\/10.1111\/fcp.12586","archive":["Portico"],"relation":{},"ISSN":["0767-3981","1472-8206"],"issn-type":[{"value":"0767-3981","type":"print"},{"value":"1472-8206","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,24]]},"assertion":[{"value":"2020-05-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}